Skip to content
10-Q

Quarterly Report

WEST PHARMACEUTICAL SERVICES INC WST

0000105770-25-000065

← back to feed
Filed
Jul 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 21, 2025 71.91M sh
Shares Diluted Q2 2025 · Jun 30, 2025 72.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 72.8M sh
Shares Diluted Q2 2025 · Jun 30, 2024 73.7M sh
Shares Diluted Q2 2025 · Jun 30, 2024 74M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $134M
Stock Repurchased Q2 2025 · Jun 30, 2024 $454.1M
Dividends Paid Q2 2025 · Jun 30, 2025 $30.3M
Dividends Paid Q2 2025 · Jun 30, 2024 $29.3M
Capex Q2 2025 · Jun 30, 2025 $146.5M
Capex Q2 2025 · Jun 30, 2024 $190.8M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $306.5M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $283.2M
Long Term Debt Q2 2025 · Jun 30, 2025 $202.6M
Long Term Debt Q2 2025 · Dec 31, 2024 $202.6M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $509.7M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $484.6M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.93B
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.68B
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.68B
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.58B
Stockholders Equity Q2 2025 · Mar 31, 2024 $2.68B
Stockholders Equity Q2 2025 · Dec 31, 2023 $2.88B
Current Liabilities Q2 2025 · Jun 30, 2025 $604.6M
Current Liabilities Q2 2025 · Dec 31, 2024 $550.4M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.02B
Total Liabilities Q2 2025 · Dec 31, 2024 $961.1M
Current Assets Q2 2025 · Jun 30, 2025 $1.68B
Current Assets Q2 2025 · Dec 31, 2024 $1.54B
Total Assets Q2 2025 · Jun 30, 2025 $3.95B
Total Assets Q2 2025 · Dec 31, 2024 $3.64B
Eps Diluted Q2 2025 · Jun 30, 2025 $1.82
Eps Diluted Q2 2025 · Jun 30, 2025 $3.05
Eps Diluted Q2 2025 · Jun 30, 2024 $1.51
Eps Diluted Q2 2025 · Jun 30, 2024 $3.06
Eps Basic Q2 2025 · Jun 30, 2025 $1.82
Eps Basic Q2 2025 · Jun 30, 2025 $3.06
Eps Basic Q2 2025 · Jun 30, 2024 $1.52
Eps Basic Q2 2025 · Jun 30, 2024 $3.09
Sga Expense Q2 2025 · Jun 30, 2025 $95.9M
Sga Expense Q2 2025 · Jun 30, 2025 $183.9M
Sga Expense Q2 2025 · Jun 30, 2024 $83M
Sga Expense Q2 2025 · Jun 30, 2024 $169.7M
Rd Expense Q2 2025 · Jun 30, 2025 $19.1M
Rd Expense Q2 2025 · Jun 30, 2025 $35.4M
Rd Expense Q2 2025 · Jun 30, 2024 $17.5M
Rd Expense Q2 2025 · Jun 30, 2024 $35.1M
Net Income Q2 2025 · Jun 30, 2025 $131.8M
Net Income Q2 2025 · Jun 30, 2025 $221.6M
Net Income Q2 2025 · Mar 31, 2025 $89.8M
Net Income Q2 2025 · Jun 30, 2024 $111.3M
Net Income Q2 2025 · Jun 30, 2024 $226.6M
Net Income Q2 2025 · Mar 31, 2024 $115.3M
Operating Income Q2 2025 · Jun 30, 2025 $153.7M
Operating Income Q2 2025 · Jun 30, 2025 $260.7M
Operating Income Q2 2025 · Jun 30, 2024 $126.2M
Operating Income Q2 2025 · Jun 30, 2024 $249M
Gross Profit Q2 2025 · Jun 30, 2025 $273.9M
Gross Profit Q2 2025 · Jun 30, 2025 $505.8M
Gross Profit Q2 2025 · Jun 30, 2024 $230M
Gross Profit Q2 2025 · Jun 30, 2024 $460.2M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $492.6M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $958.7M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $472.1M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $937.3M
Revenue Q2 2025 · Jun 30, 2025 $766.5M
Revenue Q2 2025 · Jun 30, 2025 $1.46B
Revenue Q2 2025 · Jun 30, 2024 $702.1M
Revenue Q2 2025 · Jun 30, 2024 $1.4B